Cancer treatment—androgen deprivation therapy indicator, yes/no/not applicable code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type:![]() | Data Element |
---|---|
Short name:![]() | Androgen deprivation therapy indicator |
METEOR identifier:![]() | 505444 |
Registration status:![]() | Health, Standard 14/05/2015 |
Definition:![]() | An indicator of the use of androgen deprivation therapy to reduce of androgen hormones as part of cancer treatment, as represented by a code. This includes both chemical and surgical treatments. |
Context:![]() | Androgen deprivation therapy is used to treat people with prostate cancer. |
Data Element Concept:![]() | Cancer treatment—androgen deprivation therapy indicator |
Value Domain:![]() | Yes/no/unknown code N |
Value domain attributes | ||
Representational attributes | ||
Representation class:![]() | Code | |
---|---|---|
Data type:![]() | Number | |
Format:![]() | N | |
Maximum character length:![]() | 1 | |
Value | Meaning | |
Permissible values:![]() | 1 | Yes |
2 | No | |
Supplementary values:![]() | 8 | Unknown |
Data element attributes | |
Collection and usage attributes | |
Guide for use:![]() | Record whether androgen deprivation therapy was used in the treatment of a person with prostate cancer. Androgen hormones stimulate the growth of prostate cancer cells, and so the reduction of androgen hormones aims to reduce the spread of prostate cancer. This includes both chemical treatments, such as hormone agonists and antagonists, and surgical treatment, such as an orchiectomy. |
---|---|
Collection methods:![]() | Collect from patient medical records. |
Source and reference attributes | |
Submitting organisation:![]() | Cancer Australia |
Relational attributes | |
Implementation in Data Set Specifications:![]() | Prostate cancer (clinical) NBPDS Health, Standard 14/05/2015 |
<Title>
<body>
<footer>